Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Hydrochloride Injection vs Ketanest S for General Anesthesia
CTR20232817Phase 3Completed
- Sponsor
- Chengdu Brilliant Pharmaceutical Co., Ltd.
- Start
- Sep 2023
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of Keyzilen, sponsored by Chengdu Brilliant Pharmaceutical Co., Ltd.. Started Sep 2023; status: completed.
02
Drugs
Keyzilen
Beyond the preview
Go deeper on CTR20232817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232817.